4.4 Article

Relationship of visceral and subcutaneous adipose depots to markers of arterial injury and inflammation among individuals with HIV

期刊

AIDS
卷 33, 期 2, 页码 229-236

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/QAD.0000000000002060

关键词

arterial inflammation; high-sensitivity cardiac troponin T; HIV; lipoprotein-associated phospholipase A2; oxidized low-density lipoprotein; subcutaneous adipose tissue; visceral adipose tissue

资金

  1. Gilead Sciences
  2. Roche Diagnostics
  3. Association of Nursing in AIDS Care and New England AIDS Education and Training Center
  4. KOWA
  5. Theratechnologies
  6. Bristol Myers Squibb, Inc
  7. Harvard Clinical and Translational Science Center, from the National Center for Research Resources [K23 HL092792, K23 HL136262, M01 RR01066, UL1 RR025758, UL1 TR001102]
  8. Nutrition Obesity Research Center at Harvard [P30 DK040561]

向作者/读者索取更多资源

Objective: Persons living with HIV (PLWH) well treated on antiretroviral therapies remain at risk for ensuing arterial disease. We investigated the relationship between adipose depots and biomarkers of arterial injury and inflammation to gain insight into the link between body composition and CVD risk. Designs/methods: One hundred and fifty-five HIV-infected and 70 non-HIV infected individuals were well phenotyped for body composition. Adipose depots were assessed via single-slice abdominal computed tomography (CT). Circulating markers of arterial disease and generalized inflammation [lipoprotein-associated phospholipase A2 (LpPLA2), oxidized low-density lipoprotein (oxLDL), high-sensitivity cardiac troponin T (hs-cTnT), high-sensitivity C-reactive protein (hsCRP)] were evaluated. Results: Despite similar BMI and visceral adipose tissue (VAT), HIV-infected individuals had significantly lower subcutaneous adipose tissue [SAT, 199 (126-288) vs. 239 (148-358) cm(2), P = 0.04] than non-HIV infected individuals. Among HIV-infected individuals, reduced SAT inversely correlated with LpPLA2 (rho = -0.19, P = 0.02) and hs-cTnT (rho = -0.24, P = 0.004), whereas increased VAT significantly and positively related to LpPLA2 (rho = 0.25, P = 0.003), oxLDL (rho = 0.28, P = 0.0005), hs-cTnT (rho = 0.28, P = 0.0007) and hsCRP (rho = 0.32, P = < 0.0001). Similar analyses among the non-HIV infected individuals revealed significant relationships between SAT and LpPLA2 (rho = -0.24, P = 0.05), as well as VAT and LpPLA2 (rho = 0.37, P = 0.002), oxLDL (rho = 0.24, P = 0.05) and hsCRP (rho = 0.29, P = .02). In modelling performed among the HIV group, simultaneously controlling for VAT, SAT, age and relevant HIV-related parameters, reduced SAT was an independent predictor of LpPLA2 (P = 0.04) and hs-cTnT (P = 0.005) and increased VAT was an independent predictor of LpPLA2 (P = 0.001), oxLDL (P = 0.02), hs-cTnT (P = 0.04) and hsCRP (P = 0.04). Conclusion: Fat redistribution phenotypes, characterized by SAT loss and/or VAT accumulation, may be linked to arterial injury and inflammation in HIV.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV)

Samuel R. Schnittman, Michael T. Lu, Thomas Mayrhofer, Tricia H. Burdo, Kathleen Fitch, Sara McCallum, Evelynne S. Fulda, Markella Zanni, Borek Foldyna, Carlos Malvestutto, Carl J. Fichtenbaum, Judith A. Aberg, Gerald S. Bloomfield, Edgar T. Overton, Judith Currier, Pablo Tebas, Beverly E. Sha, Heather J. Ribaudo, Jacqueline M. Flynn, Pamela S. Douglas, Kristine M. Erlandson, Steven K. Grinspoon

Summary: This study found no association between CMV IgG titer and coronary artery plaque phenotypes in HIV patients. However, CMV IgG titer was associated with certain inflammatory biomarkers. These results suggest that CMV infection may not be the primary mechanism contributing to increased cardiovascular disease risk.

CLINICAL INFECTIOUS DISEASES (2023)

Article Immunology

Increased Macrophage-Specific Arterial Infiltration Relates to Noncalcified Plaque and Systemic Immune Activation in People With Human Immunodeficiency Virus

Mabel Toribio, Moses Q. Wilks, Sandeep Hedgire, Michael T. Lu, Madeline Cetlin, Melissa Wang, Iad Alhallak, Claudia G. Durbin, Kevin S. White, Zoey Wallis, Samuel R. Schnittman, Takara L. Stanley, Georges El-Fakhri, Hang Lee, Patrick Autissier, Markella Zanni, Kenneth C. Williams, Steven K. Grinspoon

Summary: The study observed higher macrophage-specific arterial infiltration among PWH, which was related to noncalcified aortic plaque and systemic immune activation markers, potentially contributing to heightened ASCVD risk.

JOURNAL OF INFECTIOUS DISEASES (2022)

Review Immunology

Cardiovascular disease risk in women living with HIV

Katherine Kentoffio, Tecla M. Temu, Saate S. Shakil, Markella Zanni, Chris T. Longenecker

Summary: Current evidence suggests that cardiovascular disease is more prevalent among women living with HIV. The mechanisms behind this increased risk are complex, involving various factors. These factors not only contribute to the development of overt cardiovascular disease but also subclinical conditions. Therefore, cardiovascular disease remains a significant concern for women with HIV.

CURRENT OPINION IN HIV AND AIDS (2022)

Correction Multidisciplinary Sciences

Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV (vol 12, 577, 2022)

Alexander G. Bick, Konstantin Popadin, Christian W. Thorball, Md Mesbah Uddin, Markella V. Zanni, Bing Yu, Matthias Cavassini, Andri Rauch, Philip Tarr, Patrick Schmid, Enos Bernasconi, Huldrych F. Gunthard, Peter Libby, Eric Boerwinkle, Paul J. McLaren, Christie M. Ballantyne, Steven Grinspoon, Pradeep Natarajan, Jacques Fellay

SCIENTIFIC REPORTS (2022)

Article Immunology

Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus (HIV) in the United States

Markella Zanni, Borek Foldyna, Sara McCallum, Tricia H. Burdo, Sara E. Looby, Kathleen Fitch, Evelynne S. Fulda, Patrick Autissier, Gerald S. Bloomfield, Carlos D. Malvestutto, Carl J. Fichtenbaum, Edgar T. Overton, Judith A. Aberg, Kristine M. Erlandson, Thomas B. Campbell, Grant B. Ellsworth, Anandi N. Sheth, Babafemi Taiwo, Judith S. Currier, Udo Hoffmann, Michael T. Lu, Pamela S. Douglas, Heather J. Ribaudo, Steven K. Grinspoon

Summary: Among people with HIV in the United States, females have a lower prevalence of coronary plaque, specifically noncalcified or vulnerable plaque, compared to males. Additionally, there are differences in immune and inflammatory biomarkers between males and females.

CLINICAL INFECTIOUS DISEASES (2023)

Article Immunology

Plasma osteopontin relates to myocardial fibrosis and steatosis and to immune activation among women with HIV

Jake A. Robinson, Mabel Toribio, Thiago Quinaglia, Magid Awadalla, Ria Talathi, Claudia G. Durbin, Iad Alhallak, David A. Alagpulinsa, Lindsay T. Fourman, Giselle Alexandra Suero-Abreu, Michael D. Nelson, Takara L. Stanley, Christopher T. Longenecker, Lidia S. Szczepaniak, Michael Jerosch-Herold, Tomas G. Neilan, Markella V. Zanni, Tricia H. Burdo

Summary: The objective of this study was to investigate the relationship between women with HIV and heart failure risk. The study found that in women with HIV, plasma osteopontin (OPN) was positively correlated with cardiac fibrosis, myocardial steatosis, and the expression of specific monocyte subsets. These findings suggest that OPN may play an important role in the pathogenesis of heart failure in women with HIV.
Article Immunology

Sex modulates the association between inflammation and coronary atherosclerosis among older Ugandan adults with and without HIV

Saate S. Shakil, Tecla M. Temu, Cissy Kityo, Rashidah Nazzinda, Geoffrey Erem, Katherine Kentoffio, Marcio Bittencourt, Ntobeko A. B. Ntusi, Markella V. Zanni, Chris T. Longenecker

Summary: This study investigated sex differences in inflammatory markers and coronary artery disease (CAD) in sub-Saharan Africa. The results showed a stronger link between inflammation and subclinical CAD in females than in males. Sex may modulate the relationship between inflammation and CAD in this region, and further research is needed.
Article Immunology

Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIV

Pamela S. Douglas, Sara McCallum, Michael T. Lu, Triin Umbleja, Kathleen Fitch, Borek Foldyna, Markella Zanni, Evelynne S. Fulda, Gerald S. Bloomfield, Carl J. Fichtenbaum, Edgar T. Overton, Judith A. Aberg, Carlos D. Malvestutto, Tricia H. Burdo, Roberto C. Arduino, Ken S. Ho, Michael T. Yin, Heather J. Ribaudo, Steven K. Grinspoon

Summary: This study investigates the relationship between Life's Simple 7 (LS7), an assessment of cardiovascular health (CVH), and coronary plaque among people with HIV. The results show that poor CVH is associated with a higher presence of coronary plaque, and this association remains after adjusting for cardiovascular disease risk. The association between LS7 and plaque persists even after adjusting for selected biomarkers, suggesting the presence of additional protective mechanisms against atherogenesis and plaque remodeling. The clinical use of LS7 and further exploration of its relationship with coronary artery disease may enhance efforts to reduce cardiovascular morbidity and mortality in people with HIV.
Article Medicine, Research & Experimental

The importance of methods for site performance evaluation in REPRIEVE, a longitudinal, global, multicenter trial

Evelynne S. Fulda, Carl J. Fichtenbaum, Emma M. Kileel, Markella Zanni, Judith A. Aberg, Carlos Malvestutto, Sandra Wagner Cardoso, Baiba Berzins, Rita Lira, Regina Harden, Gregory Robbins, Maria Martinez, Sylvia Davila Nieves, Sara McCallum, Jorge Leon Cruz, Triin Umbleja, Heather Sprenger, Francoise Giguel, Frederic Bone, Ken Wood, Mark Byroads, Kayla Paradis, Michael T. Lu, Pamela S. Douglas, Heather J. Ribaudo, Steven K. Grinspoon, Kathleen Fitch

Summary: This study introduces a comprehensive multidimensional methodology for evaluating the performance of clinical research sites (CRSs) and assesses its impact on participant retention, data management, and specimen management. The results show that the utilization of a comprehensive approach allows for a thorough evaluation of CRS performance, facilitates data and specimen management, and enhances participant retention. This approach may serve as a guidepost for maximizing future large-scale clinical trials' operational success and scientific rigor.

CONTEMPORARY CLINICAL TRIALS (2023)

Article Multidisciplinary Sciences

Cardiac strain is lower among women with HIV in relation to monocyte activation

Mabel Toribio, Magid Awadalla, Zsofia D. Drobni, Thiago Quinaglia, Melissa Wang, Claudia G. Durbin, David A. Alagpulinsa, Lindsay T. Fourman, Giselle Alexandra Suero-Abreu, Michael D. Nelson, Takara L. Stanley, Christopher T. Longenecker, Tricia H. Burdo, Tomas G. Neilan, Markella Zanni

Summary: This study investigated the potential impacts of immune/inflammatory pathways on left ventricular systolic dysfunction among women with HIV. The results showed a correlation between inflammatory monocyte activation and lower global longitudinal strain (GLS), suggesting that targeting this immune pathway may mitigate the risks of heart failure and adverse heart failure outcomes in women with HIV.

PLOS ONE (2022)

Review Oncology

Atherosclerosis With Immune Checkpoint Inhibitor Therapy: Evidence, Diagnosis, and Management: JACC: CardioOncology State-of-the-Art Review

Giselle Alexandra Suero-Abreu, Markella Zanni, Tomas G. Neilan

Summary: This article discusses the association between immune checkpoint inhibitors (ICIs) and atherosclerotic cardiovascular events, explores the mechanisms through which ICIs affect atherosclerotic CV disease, and provides an outlook on potential strategies to reduce the risk of atherosclerosis in patients receiving ICI treatment.

JACC: CARDIOONCOLOGY (2022)

Article Immunology

Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)

Emma M. Kileel, Carlos D. Malvestutto, Janet Lo, Kathleen Fitch, Carl J. Fichtenbaum, Judith A. Aberg, Markella Zanni, Esteban Martinez, Nwora Lance Okeke, Princy Kumar, Esau Joao, Sara H. Bares, Daniel Berrner, Marek Smieja, Jhoanna C. Roa, Sara McCallum, Pamela S. Douglas, Heather J. Ribaudo, Steven K. Grinspoon

Summary: Over a 2-year follow-up period, the use of integrase strand transfer inhibitors (INSTIs) was associated with weight gain among patients who had been using INSTIs for less than 2 years at the start of the study (+0.27 kg/m(2)/year; 95% CI, .22 to .33), but not among those who had been using INSTIs for more than 2 years. The difference in weight gain between the two groups was statistically significant (P = .01).

CLINICAL INFECTIOUS DISEASES (2023)

Article Medicine, Research & Experimental

Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV

Samuel R. Schnittman, Wonyeong Jung, Kathleen V. Fitch, Markella V. Zanni, Sara McCallum, Jessica Shih-Lu Lee, Sally Shin, Brandon J. Davis, Evelynne S. Fulda, Marissa R. Diggs, Francoise Giguel, Romina Chinchay, Anandi N. Sheth, Carl J. Fichtenbaum, Carlos Malvestutto, Judith A. Aberg, Judith Currier, Douglas A. Lauffenburger, Pamela S. Douglas, Heather J. Ribaudo, Galit Alter, Steven K. Grinspoon

Summary: People with HIV (PWH) have suboptimal pathogen responses and worse COVID-19 outcomes. The effects of host factors and COVID-19 on the humoral repertoire in PWH are unclear. A comprehensive assessment reveals distinct SARS-CoV-2-specific humoral immune profiles among PWH with obesity or lower nadir CD4+ T cell count, highlighting mechanisms associated with worse COVID-19-related outcomes in this population.

JCI INSIGHT (2023)

Article Psychology, Clinical

Hormone Prescription and HIV Screening/Preventive Practices Among Clinicians Providing Care for Transgender Individuals

Mabel Toribio, Madeline Cetlin, Evelynne S. Fulda, Sarah M. Chu, Jorge Gomez Tejeda Zanudo, Tonia Poteat, Karen Donelan, Markella V. Zanni

Summary: This study investigated regional differences in gender-affirming hormone therapy (GAHT) prescribing practices and HIV screening/prevention practices among clinicians providing care to transgender individuals. The findings revealed variations in GAHT prescribing practices based on practice setting and subspecialty, as well as discrepancies in HIV screening/prevention practices among different subspecialties. The integration of GAHT and HIV screening/prevention across subspecialties could help alleviate the disproportionate burden of HIV faced by the transgender community.

TRANSGENDER HEALTH (2023)

Letter Respiratory System

Chronic Human Immunodeficiency Virus Infection Is Associated with Accelerated Decline of Forced Expiratory Volume in 1 Second among Women but Not among Men: A Longitudinal Cohort Study in Uganda

Jenna McNeill, Samson Okello, Ruth Sentongo, Bernard Kakuhikire, Alexander C. Tsai, David C. Christiani, Markella V. Zanni, Mark J. Siedner, Crystal M. North

ANNALS OF THE AMERICAN THORACIC SOCIETY (2022)

暂无数据